Literature DB >> 10522026

Hepatocellular carcinoma with tumor thrombi in the bile duct.

H J Wang1, J H Kim, J H Kim, W H Kim, M W Kim.   

Abstract

BACKGROUND/AIMS: Hepatocellular carcinoma (HCC), presenting as obstructive jaundice caused by tumor thrombi in the bile duct, is rare. The authors report on clinical experiences and evaluate the results of different treatment modalities for this disease.
METHODOLOGY: We experienced 549 cases of HCC at Ajou University Hospital from June 1994 through January 1998. Among them, 10 cases with gross evidence of tumor thrombi in the bile duct were treated with different resection methods and interventions, and then compared with those receiving short-term results.
RESULTS: Eight out of 10 patients underwent exploratory laparotomy: right lobectomy with extrahepatic bile duct resection in 2 cases; right lobectomy with tumor thrombectomy in 2 cases; left lobectomy and caudate lobectomy with extra-hepatic bile duct resection in 2 cases: T-tube drainage in 1 case and biopsy only with post-operative internal biliary stent, in 1 case. Survival times of these patients were 39 months (still alive); 38 months (still alive); 8 months (died); 8 months (died); 8 months (still alive); 1 month (still alive); 14 months (died); 8 months (died), respectively. Of the 2 non-surgical cases, 1 underwent PTBD only and the other had endoscopic removal of the thrombi. Their survival times were 18 days (died) and 24 months (still alive with recurrence), respectively. The 4 cases, with right lobectomy or left lobectomy including extrahepatic bile duct resection, had relatively long-term disease-free survival (39 months, 38 months, 8 months and 1 month after operation, respectively). However, there were no differences in survival between the partial hepatectomy procedure with removal of tumor thrombi and the simple drainage procedure without tumor resection.
CONCLUSIONS: Although the number of patients in this study is small, our results suggest that: 1) For the improvement of survival, it seems necessary to perform major hepatic resection with removal of the extrahepatic bile duct. 2) If hepatic resection cannot be accomplished with bile duct resection due to limited liver function, non-surgical modalities should be considered instead of surgery because no differences in prognosis between the 2 groups exist.

Entities:  

Mesh:

Year:  1999        PMID: 10522026

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  20 in total

Review 1.  Diffusion-weighted imaging of biliopancreatic disorders: correlation with conventional magnetic resonance imaging.

Authors:  Nam Kyung Lee; Suk Kim; Gwang Ha Kim; Dong Uk Kim; Hyung Il Seo; Tae Un Kim; Dae Hwan Kang; Ho Jin Jang
Journal:  World J Gastroenterol       Date:  2012-08-21       Impact factor: 5.742

2.  Surgical treatment of hepatocellular carcinoma with bile duct tumor thrombi.

Authors:  Bao-Gang Peng; Li-Jian Liang; Shao-Qiang Li; Fan Zhou; Yun-Peng Hua; Shi-Min Luo
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

3.  Intrahepatic bile duct recurrence of hepatocellular carcinoma without a detectable liver tumor.

Authors:  Tomoyuki Abe; Kiyoshi Kajiyama; Norifumi Harimoto; Tomonobu Gion; Ken Shirabe; Takashi Nagaie
Journal:  Int J Surg Case Rep       Date:  2012-03-28

4.  Diagnosis of bile duct hepatocellular carcinoma thrombus without obvious intrahepatic mass.

Authors:  Xue-Ying Long; Yi-Xiong Li; Wei Wu; Lang Li; Jue Cao
Journal:  World J Gastroenterol       Date:  2010-10-21       Impact factor: 5.742

5.  Hepatic resection for hepatocellular carcinoma with obstructive jaundice due to biliary tumor thrombi.

Authors:  Chun-Nan Yeh; Yi-Yin Jan; Wei-Chen Lee; Miin-Fu Chen
Journal:  World J Surg       Date:  2004-04-19       Impact factor: 3.352

6.  Diagnosis and surgical treatments of hepatocellular carcinoma with tumor thrombosis in bile duct: experience of 34 patients.

Authors:  Lun-Xiu Qin; Zeng-Chen Ma; Zhi-Quan Wu; Jia Fan; Xin-Da Zhou; Hui-Chuan Sun; Qing-Hai Ye; Lu Wang; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

7.  Surgical intervention for obstructive jaundice due to biliary tumor thrombus in hepatocellular carcinoma.

Authors:  Shu You Peng; Jian Wei Wang; Ying Bin Liu; Xiu Jun Cai; Gui Long Deng; Bin Xu; Hai Jun Li
Journal:  World J Surg       Date:  2003-11-26       Impact factor: 3.352

Review 8.  Systematic review and meta-analysis of outcomes after liver resection in patients with hepatocellular carcinoma (HCC) with and without bile duct thrombus.

Authors:  Suresh Navadgi; Chi-Chun Chang; Adam Bartlett; John McCall; Sanjay Pandanaboyana
Journal:  HPB (Oxford)       Date:  2016-02-18       Impact factor: 3.647

Review 9.  Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

10.  Surgical outcomes of hepatocellular carcinoma with bile duct tumor thrombus: a Korean multicenter study.

Authors:  Deok-Bog Moon; Shin Hwang; Hee-Jung Wang; Sung-Su Yun; Kyung Sik Kim; Young-Joo Lee; Ki-Hun Kim; Yong-Keun Park; Weiguang Xu; Bong-Wan Kim; Dong Shik Lee; Dong-Hyun Lee; Hong-Jin Kim; Jin Hong Lim; Jin Sub Choi; Yo-Han Park; Sung-Gyu Lee
Journal:  World J Surg       Date:  2013-02       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.